Apple (NASDAQ:AAPL) shares are steady rising 33 cents in pre-market hours after popping 1.46 percent on Tuesday. The company distributed invitations to an event scheduled for September 12 in San Francisco, dropping a fairly big hint that it was ready to release the next-generation iPhone. The invitation read, “It’s almost here” and featured a large shadow of the number 5, a sign that the conference is most likely the launch of the iPhone 5.
Shares of Facebook (NASDAQ:FB) are receiving a 2.77 percent boost in pre-market trading. According to a filing with the Securities and Exchange Commission, Chief Executive Officer Mark Zuckerberg has no intention of selling any of his Facebook shares for at least 12 months. Two directors, Marc Andreessen and Donald Graham will both sell shares, but only because of settle tax obligations.
Medicis Pharmaceutical (NYSE:MRX) shares edged slightly lower this morning. On Tuesday, shares surged 38 percent after news broke it was being acquired by Valeant Pharma for $2.6 billion in cash. Valeant would pay $44 in cash for each share of Medicis, 39 percent more than the stock’s Aug. 31 closing price, The New York Times reports.
Eli Lilly (NYSE:LLY) shares increased 0.46 percent in pre-market trading. The pharmaceutical giant recently received an upgrade by Bernstein to Outperform from Market Perform. Competitors such as Pfizer (NYSE:PFE) and Merck (NYSE:MRK) also edged higher.
Investor Insight: Bernanke JACKS UP Gold and Silver